Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.
BACKGROUND
Studies evaluating vitamin D status in relation to pancreatic cancer risk have yielded inconsistent results.


METHODS
We prospectively followed 118 597 participants in the Nurses' Health Study and Health Professionals Follow-up Study from 1986 to 2006. We calculated a 25-hydroxyvitamin D (25(OH)D) score from known predictors of vitamin D status for each individual and then examined the predicted 25(OH)D levels in relation to pancreatic cancer risk. Relative risks (RRs) and 95% confidence intervals (95% CIs) were estimated using Cox proportional hazards models adjusted for age, sex, race, height, smoking, and diabetes. We then further adjusted for body mass index (BMI) and physical activity in a sensitivity analysis.


RESULTS
During 20 years of follow-up, we identified 575 incident pancreatic cancer cases. Higher 25(OH)D score was associated with a significant reduction in pancreatic cancer risk; compared with the lowest quintile, participants in the highest quintile of 25(OH)D score had an adjusted RR of 0.65 (95% CI=0.50-0.86; P(trend)=0.001). Results were similar when we further adjusted for BMI and physical activity.


CONCLUSIONS
Higher 25(OH)D score was associated with a lower risk of pancreatic cancer in these two prospective cohort studies.
Bao
Y
Y
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. ying.bao@channing.harvard.edu
Ng
K
K
Wolpin
B M
BM
Michaud
D S
DS
Giovannucci
E
E
Fuchs
C S
CS
D000328:Adult; D000368:Aged; D015992:Body Mass Index; D015331:Cohort Studies; D003920:Diabetes Mellitus / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009043:Motor Activity; D015999:Multivariate Analysis; D010190:Pancreatic Neoplasms / Q000453:epidemiology*; D016016:Proportional Hazards Models; D011446:Prospective Studies; D044469:Racial Groups; D012307:Risk Factors; D012727:Sex Characteristics; D012907:Smoking / Q000453:epidemiology; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
D014807:Vitamin D; C104450:25-hydroxyvitamin D
Cancer Res. 2009 Feb 15;69(4):1439-47
19208842
J Natl Cancer Inst. 2006 Apr 5;98(7):451-9
16595781
Diabetes Care. 2007 Oct;30(10):2569-70
17626891
Cancer Causes Control. 2005 Mar;16(2):83-95
15868450
Arch Intern Med. 2009 Mar 23;169(6):626-32
19307527
Cancer Res. 2006 Oct 15;66(20):10213-9
17047087
Diabetes. 2008 Oct;57(10):2619-25
18591391
Am J Public Health. 2006 Feb;96(2):252-61
16380576
J Clin Endocrinol Metab. 2007 Jun;92(6):2017-29
17389701
Am J Epidemiol. 2004 Aug 1;160(3):248-58
15257998
Health Phys. 2004 Nov;87(5):532-8
15551791
Br J Cancer. 1997;76(8):1017-20
9376260
Carcinogenesis. 2004 Jun;25(6):1015-26
14742320
Int J Cancer. 2007 Mar 1;120(5):1123-8
17149699
BMC Cancer. 2006 Nov 10;6:264
17096841
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95
16985031
JAMA. 2001 Aug 22-29;286(8):921-9
11509056
Am J Epidemiol. 2002 May 1;155(9):783-92
11978580